IL2 and breast carcinoma: When observing the cytokine profiles of dogs with and without metastasis, IL-2 was increased in the “mammary carcinoma” group, irrespective of the metastasis status, while only dogs without metastasis in the “mammary carcinoma in the benign mixed tumor” group displayed an increase in this cytokine [120].